Quiero saber acerca de...

Federal Register / Vol. 86, No. 170 / Tuesday, September 7, 2021 / Notices ACTION:

Notice of meeting.

As required by the Federal Advisory Committee Act, the U.S.
Department of Health and Human Services HHS is hereby giving notice that the COVID19 Health Equity Task Force Task Force will hold a virtual meeting on September 30, 2021. The purpose of this meeting is to present and vote on the final recommendations for mitigating inequities caused or exacerbated by the COVID19 pandemic and for preventing such inequities in the future. This meeting is open to the public and will be live-streamed at www.hhs.gov/live. Information about the meeting will be posted on the HHS
Office of Minority Health website:
www.minorityhealth.hhs.gov/
healthequitytaskforce/ prior to the meeting.
DATES: The Task Force meeting will be held on Thursday, September 30, 2021, from 2 p.m. to approximately 6 p.m. ET
date and time are tentative and subject to change. The confirmed time and agenda will be posted on the COVID19
Health Equity Task Force web page:
www.minorityhealth.hhs.gov/
healthequitytaskforce/ when this information becomes available.
FOR FURTHER INFORMATION CONTACT:
Samuel Wu, Designated Federal Officer for the Task Force; Office of Minority Health, Department of Health and Human Services, Tower Building, 1101
Wootton Parkway, Suite 100, Rockville, Maryland 20852. Phone: 2404536173;
email: COVID19HETF@hhs.gov.
SUPPLEMENTARY INFORMATION:
Background: The COVID19 Health Equity Task Force Task Force was established by Executive Order 13995, dated January 21, 2021. The Task Force is tasked with providing specific recommendations to the President, through the Coordinator of the COVID
19 Response and Counselor to the President COVID19 Response Coordinator, for mitigating the health inequities caused or exacerbated by the COVID19 pandemic and for preventing such inequities in the future. The Task Force shall submit a final report to the COVID19 Response Coordinator addressing any ongoing health inequities faced by COVID19 survivors that may merit a public health response, describing the factors that contributed to disparities in COVID19 outcomes, and recommending actions to combat such disparities in future pandemic responses.
The meeting is open to the public and will be live-streamed at www.hhs.gov/
live. No registration is required. A
public comment session will be held
sradovich on DSKJLST7X2PROD with NOTICES

SUMMARY:

VerDate Sep<11>2014

00:30 Sep 04, 2021

Jkt 253001

during the meeting. Pre-registration is required to provide public comment during the meeting. To pre-register, please send an email to COVID19HETF@hhs.gov and include your name, title, and organization by close of business on Friday, September 24, 2021. Comments will be limited to no more than three minutes per speaker and should be pertinent to the meeting discussion. Individuals are encouraged to provide a written statement of any public comments for accurate minutetaking purposes. If you decide you would like to provide public comment but do not pre-register, you may submit your written statement by emailing COVID19HETF@hhs.gov no later than close of business on Thursday, October 7, 2021. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should contact: COVID19HETF@hhs.gov and reference this meeting. Requests for special accommodations should be made at least 10 business days prior to the meeting.
Dated: September 1, 2021.
Samuel Wu, Designated Federal Officer, COVID19 Health Equity Task Force.

50139

Agenda: To review and evaluate grant applications.
Place: Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 6710B Rockledge Drive, Room 2137D, Bethesda, MD 20892 Video-Assisted Meeting.
Contact Person: Helen Huang, Ph.D., Scientific Review Officer, Scientific Review Branch, Eunice Kennedy Shriver Institute of Child Health and Human Development, National Institutes of Health, 6710B
Rockledge Drive, Room 2137D, Bethesda, MD
20892, 301 4358207, helen.huang@
nih.gov.
Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS
Dated: September 2, 2021.
Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202119354 Filed 9321; 8:45 am BILLING CODE 414001P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
FR Doc. 202119322 Filed 9321; 8:45 am
Center for Scientific Review; Notice of Closed Meetings
BILLING CODE 415029P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed Meeting Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Child Health and Human Development Initial Review Group; Function, Integration, and Rehabilitation Sciences Study Section.
Date: October 22, 2021.
Time: 10:00 a.m. to 6:00 p.m.

PO 00000

Frm 00128

Fmt 4703

Sfmt 4703

U:07SEN1.SGM

Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Molecular, Cellular and Developmental Neuroscience Integrated Review Group Neurogenesis and Cell Fate Study Section.
Date: October 67, 2021.
Time: 11:00 a.m. to 9:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 Virtual Meeting.
Contact Person: Joanne T. Fujii, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4184, MSC 7850, Bethesda, MD 20892, 301 435
1178, fujiij@csr.nih.gov.

07SEN1